ArticleThe Lancet regional health. Southeast Asia2024

Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trial.

Budhi Singh Yadav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.